Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Copy‐number variation of <i>MCL1</i> predicts overall survival of non‐small‐cell lung cancer in a Southern Chinese population

5 Jun 2016

Abstract excerpt

BCL2L1 and MCL1 are key anti-apoptotic genes, and critical for cancer progression. The prognostic values of BCL2L1 and MCL1 copy-number variations (CNVs) in non-small-cell lung cancer (NSCLC) remain largely unknown. Somatic CNVs in BCL2L1 and MCL1 genes were tested in tumor tissues from 516 NSCLC patients in southern China; afterward, survival analyses were conducted with overall survival (OS) as outcome....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer-related Molecular Pathways
Share to Genomic variations and chromosomal abnormalities

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27264345
DOI: 10.1002/cam4.774

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Copy‐number variation of <i>MCL1</i> predicts overall survival of non‐small‐cell lung cancer in a Southern Chinese populationPMID 27264345Read ↗

MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expressionSemantic proximity Read ↗

Genetic variation in BCL2 3'-UTR was associated with lung cancer risk and prognosis in male Chinese population.Semantic proximity Read ↗

Impact of copy number variant and single nucleotide polymorphism of the programmed death‑ligand 1 gene, programmed death‑ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non‑small cell lung carcinomaSemantic proximity Read ↗

Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer.Semantic proximity Read ↗

Screening of lung cancer related SNPs and CNVs with SNP microarrays.Semantic proximity Read ↗

A functional copy-number variation in MAPKAPK2 predicts risk and prognosis of lung cancer.Semantic proximity Read ↗

Effect of the BCL2 gene polymorphism on survival in advanced-stage non-small cell lung cancer patients who received chemotherapy.Semantic proximity Read ↗

The average copy number variation (CNVA) of chromosome fragments is a potential surrogate marker for TMB in predicting responses to immunotherapy in Non-small cell lung cancerSemantic proximity Read ↗

Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.Semantic proximity Read ↗

MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.Semantic proximity Read ↗

Functional regulatory variants of MCL1 contribute to enhanced promoter activity and reduced risk of lung cancer in nonsmokers: implications for context-dependent phenotype of an antiapoptotic and antiproliferative gene in solid tumor.Semantic proximity Read ↗

MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.